aTyr Pharma reported $1.84M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Ardelyx USD 207.61M 968K Sep/2025
aTyr Pharma USD 1.84M 8K Sep/2025
Biogen USD 6.56B 275.1M Mar/2026
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Grifols EUR 9.23B 626.05M Dec/2024
Lakefront Biotherapeutics EUR 6.44M 480K Mar/2026
Novartis USD 47B 11.62B Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
United Therapeutics USD 200M 100M Mar/2025
Xoma USD 120.79M 3.27M Jun/2024